BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 34206708)

  • 1. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD.
    Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
    Ferrario CM; Strawn WB
    Am J Cardiol; 2006 Jul; 98(1):121-8. PubMed ID: 16784934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis.
    Durante A; Peretto G; Laricchia A; Ancona F; Spartera M; Mangieri A; Cianflone D
    Curr Pharm Des; 2012; 18(7):981-1004. PubMed ID: 22283771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
    Partigulova AS; Naumov VG
    Kardiologiia; 2010; 50(10):50-5. PubMed ID: 21118180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods in the evaluation of cardiovascular renin angiotensin aldosterone activation and oxidative stress.
    Manrique C; Lastra G; Habibi J; Wei Y; Morris EM; Stump CS; Sowers JR
    Methods Mol Med; 2007; 139():163-79. PubMed ID: 18287671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blockade of renin-angiotensin-aldosterone system in hemodialysis patients to control hypertension and prevent cardiovascular disease: optimal pharmacotherapy.
    Morishita Y; Kusano E
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):241-6. PubMed ID: 22023537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease.
    Bernardi S; Michelli A; Zuolo G; Candido R; Fabris B
    J Diabetes Res; 2016; 2016():8917578. PubMed ID: 27652272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiological role of tissue renin-angiotensin-aldosterone system (RAAS) in human atherosclerosis].
    Fukui K; Yamada H; Matsubara H
    Nihon Rinsho; 2012 Sep; 70(9):1556-61. PubMed ID: 23012803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
    Hayashi T; Takai S; Yamashita C
    Curr Vasc Pharmacol; 2010 Mar; 8(2):189-97. PubMed ID: 19485896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke.
    Sokol SI; Portnay EL; Curtis JP; Nelson MA; Hebert PR; Setaro JF; Foody JM
    Neurology; 2004 Jul; 63(2):208-13. PubMed ID: 15277610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin-aldosterone system as a target in coronary disease.
    O'Keefe JH; Lurk JT; Kahatapitiya RC; Haskin JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):124-30. PubMed ID: 12573198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond.
    Epstein BJ; Leonard PT; Shah NK
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):713-25. PubMed ID: 22894628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
    Lambers Heerspink HJ; Perkovic V; de Zeeuw D
    J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.
    Montecucco F; Pende A; Mach F
    Mediators Inflamm; 2009; 2009():752406. PubMed ID: 19390623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.
    Trošt Rupnik A; Pajek J; Guček A; Osredkar J; Kovač D; Bren A; Klančič D; Saksida S; Rus I; Globokar M; Drozg A; Lešnik M; Plešivčnik Z; Ekart R; Lopert S; Lindič J
    Ther Apher Dial; 2013 Aug; 17(4):425-30. PubMed ID: 23931884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis].
    Hirata Y; Fukuda D; Sata M
    Nihon Rinsho; 2011 Jan; 69(1):55-9. PubMed ID: 21226261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse.
    Tikellis C; Pickering RJ; Tsorotes D; Huet O; Chin-Dusting J; Cooper ME; Thomas MC
    Hypertension; 2012 Jul; 60(1):98-105. PubMed ID: 22647892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.